Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Raghu G et al. – HRQL and dyspnoea changed minimally during the course of the study. Observations from exploratory analyses suggest benefits of bosentan on HRQL among patients who underwent SLB for diagnosis and merit further investigation.

Related Articles

Tumor necrosis factor inhibitors and lung disease: A paradox of efficacy and risk
Seminars in Arthritis and Rheumatism, 11/20/09    Relevance Score: 68%

Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine, 10/28/09    Relevance Score: 68%

Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients
Annals of Thoracic Medicine, 10/02/09    Relevance Score: 68%

The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis
Journal of Leukocyte Biology, 11/11/09    Relevance Score: 67%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09    Relevance Score: 67%

Today in Cystic Fibrosis...keeping you current

Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis
European Respiratory Journal , 11/24/09

Continuous vs Thrice-Daily Ceftazidime for Elective Intravenous Antipseudomonal Therapy in Cystic Fibrosis
Infection, 09/22/09

Lung Transplantation in Patients with Cystic Fibrosis
Seminars in Respiratory and Critical Care Medicine, 09/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address